Source link : https://newshealth.biz/health-news/chemotherapy-free-combo-improves-survival-in-metastatic-colorectal-cancer/
(MedPage Today) — BERLIN — The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly improved overall survival (OS) among previously treated patients with metastatic colorectal cancer, a phase… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118047 Author : Publish date : 2025-10-20 21:11:00 Copyright for syndicated content belongs to the linked Source.
The post Chemotherapy-Free Combo Improves Survival in Metastatic Colorectal Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-20 21:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8